Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population.

Amin, Alpesh; Stokes, Michael; Makenbaeva, Dinara; Wiederkehr, Daniel; Wu, Ning; Lawrence, John H

Amin, Alpesh; Stokes, Michael; Makenbaeva, Dinara; Wiederkehr, Daniel; Wu, Ning; Lawrence, John H.

Affiliation

Amin A; University of California , Irvine, CA , USA.

J Med Econ ; 17(11): 771-81, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25133458

Subject(s)

Anticoagulants/economics; Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Health Expenditures/statistics & numerical data; Aged; Anticoagulants/adverse effects; Benzimidazoles/economics; Benzimidazoles/therapeutic use; Dabigatran; Female; Hemorrhage/chemically induced; Humans; Male; Middle Aged; Morpholines/economics; Morpholines/therapeutic use; Pyrazoles/economics; Pyrazoles/therapeutic use; Pyridones/economics; Pyridones/therapeutic use; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke/economics; Stroke/prevention & control; Thiophenes/economics; Thiophenes/therapeutic use; Warfarin/economics; Warfarin/therapeutic use; beta-Alanine/analogs & derivatives; beta-Alanine/economics; beta-Alanine/therapeutic use

Key words

Anticoagulants; Costs; Medical cost reduction; Resource use; Stroke

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Health Expenditures / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google